feed,title,long_url,short_url
🔐MarketWatch,FDA approves Reata’s rare disease drug amid questions about changes to the regulatory environment for neuroscience treatments,http://www.marketwatch.com/news/story.asp?guid=%7B20C06575-04D4-B545-71A5-89DF29346CDC%7D&siteid=rss&rss=1,https://da.gd/WsaEV6
🔐MarketWatch,Crypto: Visa says crypto strategy unchanged after a report that it’s pausing new partnership efforts,http://www.marketwatch.com/news/story.asp?guid=%7B20C06575-04D4-B545-71A5-7ED861FB9A96%7D&siteid=rss&rss=1,https://da.gd/WEx5d
🔐MarketWatch,Earnings Results: Novavax stock shedding a quarter of its value as vaccine maker’s business in ‘substantial doubt’,http://www.marketwatch.com/news/story.asp?guid=%7B20C06575-04D4-B545-71A6-2B350A73C5A5%7D&siteid=rss&rss=1,https://da.gd/xuIUhg
🔐MarketWatch,PRO Act introduced for third time as lawmakers cite growing unionization push,http://www.marketwatch.com/news/story.asp?guid=%7B20C06575-04D4-B545-71A5-F6311D30E0A3%7D&siteid=rss&rss=1,https://da.gd/j9grL
